nach oben

Pediatric Cardiology

Erschienen in:

01.04.2011 | Original Article

The Functions of Endothelial Progenitor Cells Were Significantly Improved After Treatment With Intravenous Immunoglobulin and Aspirin in Children With Kawasaki Disease

verfasst von: Ming Guo Xu, Li Na Men, Ying Zu, Chun Yu Zhao, Xiang Chun Meng, Tao Wang

Erschienen in: Pediatric Cardiology | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

We sought to determine the effects of treatment with intravenous immunoglobulin (IVIG) and aspirin on the functions of endothelial progenitor cells (EPCs) in patients with Kawasaki disease (KD) as well as its relationship with concentrations of tumor necrosis factor-α (TNF-α) and high-sensitivity C-reactive protein (hs-CRP). Ten KD patients in the acute phase of their disease were recruited. We investigated EPC functions in children with KD before and after treatment with IVIG and aspirin. In vitro assays were used to measure the functions, including proliferation, adhesion, and migration activities, of EPCs. Plasma levels of TNF-α and hs-CRP were also assessed. All of the data were assessed before and at 7 days after treatment initiation. EPC functions after 7 days of treatment with IVIG and aspirin were significantly improved than they were before treatment with IVIG and aspirin. Treatment with IVIG and aspirin significantly decreased TNF-α and hs-CRP concentrations. There was a significant linear regression relationship between decreased plasma TNF-α levels, hs-CRP levels, and increased functions of circulating EPCs. The results of our study indicate that the functions of circulating EPCs improved after treatment with IVIG and aspirin, which may be related to decreased concentrations of TNF-α and hs-CRP.

Ahn SY, Jang GC, Shin JS, Shin KM, Kim DS (2003) Tumor necrosis factor-alpha levels and promoter polymorphism in patients with Kawasaki disease in Korea. Yonsei Med J 44(6):1021–1026PubMed

Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T et al (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275(5302):964–967PubMedCrossRef

Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H et al (1999) VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. Embo J 18(14):3964–3972PubMedCrossRef

Brogan PA, Bose A, Burgner D, Shingadia D, Tulloh R, Michie C et al (2002) Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research. Arch Dis Child 86(4):286–290PubMedCrossRef

Brogan PA, Shah V, Klein N, Dillon MJ (2004) Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury. Arthritis Rheum 50(2):589–597PubMedCrossRef

Burns JC, Glode MP (2004) Kawasaki syndrome. Lancet 364(9433):533–544PubMedCrossRef

Chen J, Huang L, Song M, Yu S, Gao P, Jing J (2009) C-reactive protein upregulates receptor for advanced glycation end products expression and alters antioxidant defenses in rat endothelial progenitor cells. J Cardiovasc Pharmacol 53(5):359–367PubMedCrossRef

Fujii H, Li SH, Szmitko PE, Fedak PW, Verma S (2006) C-reactive protein alters antioxidant defenses and promotes apoptosis in endothelial progenitor cells. Arterioscler Thromb Vasc Biol 26(11):2476–2482PubMedCrossRef

Fukazawa R, Ogawa S (2009) Long-term prognosis of patients with Kawasaki disease: at risk for future atherosclerosis? J Nippon Med School 76(3):124–133CrossRef

10.

Furukawa S, Matsubara T, Ichiyama T (2008) Regulation of proinflammatory cytokine cascade in Kawasaki disease. Nippon Rinsho 66(2):258–264PubMed

11.

He T, Smith LA, Harrington S, Nath KA, Caplice NM, Katusic ZS (2004) Transplantation of circulating endothelial progenitor cells restores endothelial function of denuded rabbit carotid arteries. Stroke 35(10):2378–2384PubMedCrossRef

12.

Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA et al (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348(7):593–600PubMedCrossRef

13.

Hui-Yuen JS, Duong TT, Yeung RS (2006) TNF-alpha is necessary for induction of coronary artery inflammation and aneurysm formation in an animal model of Kawasaki disease. J Immunol 176(10):6294–6301PubMed

14.

Kawasaki T (1967) Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 16(3):178–222PubMed

15.

Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H (1974) A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 54(3):271–276PubMed

16.

Lau AC, Duong TT, Ito S, Wilson GJ, Yeung RS (2009) Inhibition of matrix metalloproteinase-9 activity improves coronary outcome in an animal model of Kawasaki disease. Clin Exp Immunol 157(2):300–309PubMedCrossRef

17.

Lau AC, Duong TT, Ito S, Yeung RS (2009) Intravenous immunoglobulin and salicylate differentially modulate pathogenic processes leading to vascular damage in a model of Kawasaki disease. Arthritis Rheum 60(7):2131–2141PubMedCrossRef

18.

Matsubara T, Furukawa S, Yabuta K (1990) Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions. Clin Immunol Immunopathol 56(1):29–36PubMedCrossRef

19.

Mitani Y, Sawada H, Hayakawa H, Aoki K, Ohashi H, Matsumura M et al (2005) Elevated levels of high-sensitivity C-reactive protein and serum amyloid A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease. Circulation 111(1):38–43PubMedCrossRef

20.

Musunuru K, Kral BG, Blumenthal RS, Fuster V, Campbell CY, Gluckman TJ et al (2008) The use of high-sensitivity assays for C-reactive protein in clinical practice. Nat Clin Pract Cardiovasc Med 5(10):621–635PubMedCrossRef

21.

Nabata A, Kuroki M, Ueba H, Hashimoto S, Umemoto T, Wada H et al (2008) C-reactive protein induces endothelial cell apoptosis and matrix metalloproteinase-9 production in human mononuclear cells: implications for the destabilization of atherosclerotic plaque. Atherosclerosis 196(1):129–135PubMedCrossRef

22.

Niboshi A, Ozawa S, Hamaoka K (2008) Kawasaki disease and atherosclerosis. Nippon Rinsho 66(2):387–392PubMed

23.

Pinna GS, Kafetzis DA, Tselkas OI, Skevaki CL (2008) Kawasaki disease: an overview. Curr Opin Infect Dis 21(3):263–270PubMedCrossRef

24.

Tatara K, Kusakawa S, Itoh K, Kazuma N, Lee K, Hashimoto K et al (1989) Long-term prognosis of Kawasaki disease patients with coronary artery obstruction. Heart Vessels 5(1):47–51PubMedCrossRef

25.

Terai M, Shulman ST (1997) Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. J Pediatr 131(6):888–893PubMedCrossRef

26.

Walter DH, Rittig K, Bahlmann FH, Kirchmair R, Silver M, Murayama T et al (2002) Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 105(25):3017–3024PubMedCrossRef

27.

Werner N, Junk S, Laufs U, Link A, Walenta K, Bohm M et al (2003) Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 93(2):e17–e24PubMedCrossRef

28.

Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A et al (2005) Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353(10):999–1007PubMedCrossRef

29.

Xu MG, Wang JM, Chen L, Wang Y, Yang Z, Tao J (2009) Berberine-induced upregulation of circulating endothelial progenitor cells is related to nitric oxide production in healthy subjects. Cardiology 112(4):279–286PubMedCrossRef

30.

Xu MG, Men LN, Zhao CY, Zhao X, Wang YX, Meng XC et al (2010) The number and function of circulating endothelial progenitor cells in patients with Kawasaki disease. Eur J Pediatr 169(3):289–296PubMedCrossRef

31.

Zhang Y, Herbert BS, Rajashekhar G, Ingram DA, Yoder MC, Clauss M et al (2009) Premature senescence of highly proliferative endothelial progenitor cells is induced by tumor necrosis factor-alpha by way of the p38 mitogen-activated protein kinase pathway. Faseb J 23(5):1358–1365PubMedCrossRef

Titel: The Functions of Endothelial Progenitor Cells Were Significantly Improved After Treatment With Intravenous Immunoglobulin and Aspirin in Children With Kawasaki Disease
verfasst von: Ming Guo Xu
Li Na Men
Ying Zu
Chun Yu Zhao
Xiang Chun Meng
Tao Wang
Publikationsdatum: 01.04.2011
Verlag: Springer-Verlag
Erschienen in: Pediatric Cardiology / Ausgabe 4/2011
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI: https://doi.org/10.1007/s00246-011-9900-4

Neu im Fachgebiet Kardiologie

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2011

Ventricular Repolarization Lability in Children With Kawasaki Disease

Atypical Shone’s Complex Diagnosed by Echocardiography

Congenital Cardiac Defects: A Possible Association of Aminopterin Syndrome and In Utero Methotrexate Exposure?

Clinical Relevance of Different B-Type Natriuretic Peptide Decisional Cutoff Values for the Diagnosis of Congenital Heart Disease in the First Weeks of Life